U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with O

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
138115 Q3 2022 OPADRY 03B82849 YELLOW ORAL TABLET 20.00 mg 40mg Deletion
138116 Q3 2022 OPASPRAY K-1-2275 YELLOW ORAL TABLET NA Deletion
138117 Q3 2022 OPASPRAY K-1-3197 GREEN ORAL TABLET 1.12 mg Deletion
138331 Q2 2022 OPADRY II 85F34610 PINK ORAL TABLET 4.00 mg MDE Replacement
138332 Q3 2022 OPADRY II 85F34610 PINK ORAL TABLET 8mg MDE Replacement
138333 Q2 2022 OPADRY II 85F48105 ORAL TABLET 1.50 mg MDE Replacement
138334 Q3 2022 OPADRY II 85F48105 ORAL TABLET 32mg MDE Replacement
138335 Q2 2022 OPADRY II YS-1-19025A CLEAR ORAL GRANULE, FOR SUSPENSION 7.08 mg MDE Replacement
138336 Q3 2022 OPADRY II YS-1-19025A CLEAR ORAL GRANULE, FOR SUSPENSION 14mg MDE Replacement
138337 Q2 2022 OPADRY OY-7300 WHITE ORAL TABLET 35.00 mg MDE Replacement
138338 Q3 2022 OPADRY OY-7300 WHITE ORAL TABLET 95mg MDE Replacement
138339 Q2 2022 OPADRY YELLOW ORAL TABLET, EXTENDED RELEASE 13.20 mg MDE Replacement
138340 Q3 2022 OPADRY YELLOW ORAL TABLET, EXTENDED RELEASE 47mg MDE Replacement
138341 Q2 2022 OPADRY YS-1-14129 PINK ORAL CAPSULE, EXTENDED RELEASE 9.00 mg MDE Replacement
138342 Q3 2022 OPADRY YS-1-14129 PINK ORAL CAPSULE, EXTENDED RELEASE 9mg MDE Replacement
138343 Q2 2022 OPADRY YS-3-7413 CLEAR ORAL TABLET, EXTENDED RELEASE 4.00 mg MDE Replacement
138344 Q3 2022 OPADRY YS-3-7413 CLEAR ORAL TABLET, EXTENDED RELEASE 35mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: July 1, 2022
Database Last Updated: July 18, 2022

Back to Top